Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Siltuximab for Multicentric Castleman Disease-Letter.
Teipel R, Ordemann R, Proske U, Dietrich F, Mende M, Ehninger G, Kroschinsky F, Platzbecker U. Teipel R, et al. Among authors: ordemann r. Clin Cancer Res. 2015 Oct 15;21(20):4740. doi: 10.1158/1078-0432.CCR-15-1310. Clin Cancer Res. 2015. PMID: 26473194 No abstract available.
Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia.
Bornhäuser M, Illmer T, Oelschlaegel U, Schetelig J, Ordemann R, Schaich M, Hänel M, Schuler U, Thiede C, Kiani A, Platzbecker U, Ehninger G. Bornhäuser M, et al. Among authors: ordemann r. Clin Cancer Res. 2008 Sep 1;14(17):5585-93. doi: 10.1158/1078-0432.CCR-08-0894. Clin Cancer Res. 2008. PMID: 18765552 Clinical Trial.
Modified DHAP regimen in the salvage treatment of refractory or relapsed lymphomas.
Kroschinsky F, Röllig D, Riemer B, Kramer M, Ordemann R, Schetelig J, Bornhäuser M, Ehninger G, Hänel M. Kroschinsky F, et al. Among authors: ordemann r. J Cancer Res Clin Oncol. 2019 Dec;145(12):3067-3073. doi: 10.1007/s00432-019-03027-6. Epub 2019 Sep 28. J Cancer Res Clin Oncol. 2019. PMID: 31563974
Hip pain in medulloblastoma as first symptom of extraneural relapse.
Sockel K, Ordemann R, von Bonin M, Jahn S, Prange-Krex G, Ehninger G, Kroschinsky F. Sockel K, et al. Among authors: ordemann r. Onkologie. 2011;34(4):196-8. doi: 10.1159/000327002. Epub 2011 Mar 23. Onkologie. 2011. PMID: 21447979 No abstract available.
Differences in Cellular Composition of Peripheral Blood Stem Cell Grafts from Healthy Stem Cell Donors Mobilized with Either Granulocyte Colony-Stimulating Factor (G-CSF) Alone or G-CSF and Plerixafor.
Teipel R, Oelschlägel U, Wetzko K, Schmiedgen M, Kramer M, Rücker-Braun E, Hölig K, von Bonin M, Heidrich K, Fuchs A, Ordemann R, Kroschinsky F, Bornhäuser M, Hütter G, Schmidt H, Ehninger G, Schetelig J, Heidenreich F. Teipel R, et al. Among authors: ordemann r. Biol Blood Marrow Transplant. 2018 Nov;24(11):2171-2177. doi: 10.1016/j.bbmt.2018.06.023. Epub 2018 Jun 21. Biol Blood Marrow Transplant. 2018. PMID: 29935214 Free article.
Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
Kroschinsky F, Hölig K, Platzbecker U, Poppe-Thiede K, Ordemann R, Blechschmidt M, Oelschlaegel U, Schaich M, Hänel M, Bornhäuser M, Ehninger G. Kroschinsky F, et al. Among authors: ordemann r. Transfusion. 2006 Aug;46(8):1417-23. doi: 10.1111/j.1537-2995.2006.00911.x. Transfusion. 2006. PMID: 16934080 Clinical Trial.
Assessment of dysplastic hematopoiesis: lessons from healthy bone marrow donors.
Parmentier S, Schetelig J, Lorenz K, Kramer M, Ireland R, Schuler U, Ordemann R, Rall G, Schaich M, Bornhäuser M, Ehninger G, Kroschinsky F. Parmentier S, et al. Among authors: ordemann r. Haematologica. 2012 May;97(5):723-30. doi: 10.3324/haematol.2011.056879. Epub 2011 Dec 16. Haematologica. 2012. PMID: 22180437 Free PMC article.
Selective expansion of regulatory T cells during lenalidomide treatment of myelodysplastic syndrome with isolated deletion 5q.
Balaian E, Schuster C, Schönefeldt C, Germing U, Haase D, Tuve S, Ordemann R, Ehninger G, Bornhäuser M, Oelschlaegel U, Mohr B, von Bonin M, Platzbecker U, Wermke M. Balaian E, et al. Among authors: ordemann r. Ann Hematol. 2016 Oct;95(11):1805-10. doi: 10.1007/s00277-016-2775-y. Epub 2016 Aug 10. Ann Hematol. 2016. PMID: 27510179 Clinical Trial.
Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
Hölig K, Schmidt H, Hütter G, Kramer M, Teipel R, Heidrich K, Zimmer K, Heidenreich F, Blechschmidt M, Torosian T, Ordemann R, Kroschinsky F, Rücker-Braun E, Gopsca L, Wagner-Drouet EM, Oelschlaegel U, Schmidt AH, Bornhäuser M, Ehninger G, Schetelig J. Hölig K, et al. Among authors: ordemann r. Bone Marrow Transplant. 2021 Mar;56(3):635-645. doi: 10.1038/s41409-020-01053-4. Epub 2020 Oct 7. Bone Marrow Transplant. 2021. PMID: 33028987 Free PMC article. Clinical Trial.
Correction to: Salvage treatment with plerixafor in poor mobilizing allogeneic stem cell donors: results of a prospective phase II-trial.
Hölig K, Schmidt H, Hütter G, Kramer M, Teipel R, Heidrich K, Zimmer K, Heidenreich F, Blechschmidt M, Torosian T, Ordemann R, Kroschinsky F, Rücker-Braun E, Gopsca L, Wagner-Drouet EM, Oelschlaegel U, Schmidt AH, Bornhäuser M, Ehninger G, Schetelig J. Hölig K, et al. Among authors: ordemann r. Bone Marrow Transplant. 2022 Jan;57(1):143. doi: 10.1038/s41409-021-01523-3. Bone Marrow Transplant. 2022. PMID: 34773089 Free PMC article. No abstract available.
57 results